Skip to content
10-Q

Quarterly Report

Curanex Pharmaceuticals Inc CURX

0001493152-25-012880

← back to feed
Filed
Sep 9, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Sep 9, 2025 27.75M sh
Shares Diluted Q2 2025 · Jun 30, 2025 24M sh
Shares Diluted Q2 2025 · Jun 30, 2025 24M sh
Shares Diluted Q2 2025 · Jun 30, 2024 2.4M sh
Shares Diluted Q2 2025 · Jun 30, 2024 2.4M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$440.03K
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$330.21K
Stockholders Equity Q2 2025 · Jun 30, 2025 $305.43K
Stockholders Equity Q2 2025 · Mar 31, 2025 $365.78K
Stockholders Equity Q2 2025 · Dec 31, 2024 $503.36K
Stockholders Equity Q2 2025 · Jun 30, 2024 $715.23K
Stockholders Equity Q2 2025 · Mar 31, 2024 $129.89K
Stockholders Equity Q2 2025 · Dec 31, 2023 $60.09K
Current Liabilities Q2 2025 · Jun 30, 2025 $75.93K
Current Liabilities Q2 2025 · Dec 31, 2024 $14.58K
Total Liabilities Q2 2025 · Jun 30, 2025 $481.74K
Total Liabilities Q2 2025 · Dec 31, 2024 $14.58K
Current Assets Q2 2025 · Jun 30, 2025 $711.34K
Current Assets Q2 2025 · Dec 31, 2024 $517.94K
Total Assets Q2 2025 · Jun 30, 2025 $787.17K
Total Assets Q2 2025 · Dec 31, 2024 $517.94K
Eps Diluted Q2 2025 · Jun 30, 2025 $0.00
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.01
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.02
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.05
Eps Basic Q2 2025 · Jun 30, 2025 $0.00
Eps Basic Q2 2025 · Jun 30, 2025 −$0.01
Eps Basic Q2 2025 · Jun 30, 2024 −$0.02
Eps Basic Q2 2025 · Jun 30, 2024 −$0.05
Sga Expense Q2 2025 · Jun 30, 2025 $57.66K
Sga Expense Q2 2025 · Jun 30, 2025 $195.11K
Sga Expense Q2 2025 · Jun 30, 2024 $44.2K
Sga Expense Q2 2025 · Jun 30, 2024 $124.4K
Net Income Q2 2025 · Jun 30, 2025 −$60.35K
Net Income Q2 2025 · Jun 30, 2025 −$197.93K
Net Income Q2 2025 · Mar 31, 2025 −$137.58K
Net Income Q2 2025 · Jun 30, 2024 −$44.2K
Net Income Q2 2025 · Jun 30, 2024 −$124.4K
Net Income Q2 2025 · Mar 31, 2024 −$80.2K
Operating Income Q2 2025 · Jun 30, 2025 −$57.66K
Operating Income Q2 2025 · Jun 30, 2025 −$195.11K
Operating Income Q2 2025 · Jun 30, 2024 −$44.2K
Operating Income Q2 2025 · Jun 30, 2024 −$124.4K